论文部分内容阅读
对细胞分化剂进行了溶血试验、过敏试验、热原试验、静脉注射的最大耐受量试验和LD50等安全性试验，结果溶血试验、过敏试验、热原试验符合中国药典注射液的要求，LD50为4742mg／kg。临床治疗肿瘤病人有效率达77％。
Hemolysis test, allergy test, pyrogen test, maximum tolerability test of intravenous injection and LD50 safety test of cell differentiation agent were carried out. Results Hemolysis test, allergy test and pyrogen test were in accordance with the requirements of Chinese Pharmacopoeia injection. LD50 For 4742mg / kg. Clinical treatment of cancer patients effective rate of 77%.